Search
Prenetics Global Ltd
PREAdd to Watchlist
18.640USD
-0.600-3.12%
Close 07-31 16:00（ET）Quotes delayed by 15 min
319.55MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Prenetics Global Ltd is 8.00, ranking 171 out of 385 in the Biotechnology & Medical Research industry. The average price target is 31.00, with a high of 31.00 and a low of 31.00.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
33.000
Target Price
+77.04%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Prenetics Global Ltd
PRE
3
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
Kymera Therapeutics Inc
KYMR
24
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Prenetics Global Ltd's expected revenue for the next quarter?
Prenetics Global Ltd's expected revenue is 48.92M.
What is Prenetics Global Ltd's price target?
Analysts forecast that Prenetics Global Ltd's price target is USD 31.00, with the highest forecast at USD 31.00 and the lowest forecast at USD 31.00.
How have Prenetics Global LtdPRE's recent earnings per share performed?
The market expectation was USD -1.36, while Prenetics Global LtdPRE's earnings per share (EPS) for the previous quarter was USD -0.47. EPS for the next quarter is expected at USD -0.71.
What is the analyst rating for Prenetics Global Ltd?
Based on the ratings of Prenetics Global Ltd's stock from 3 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.